In summary, augmenting early insulin secretion is a remarkably effective mechanism to control postprandial hyperglycemia. Low-dose nateglinide could be used to determine the potential of this ...

This multicenter, double-blind, randomized, parallel-group fixed-dose study of 8 weeks' duration was performed to define the maximum tolerated dose of nateglinide in a prediabetic population.